Safety and Efficacy Study of Single-Dose Oral CEM-101 in Patients With Uncomplicated Urogenital Gonorrhea

NCT01591447 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Uncomplicated Urogenital Gonorrhea

Interventions

DRUG: solithromycin
DRUG: Solithromycin (CEM-101)

Sponsor

Melinta Therapeutics, Inc.